Compare metabolites in 2 of these studies:
Study A:   Study B:  

List of Studies ( Metabolite:GM2 36:1;O2)

Study_idAnalysis_idStudy_titleSourceSpeciesDiseaseInstituteAnalysis Type
ST004217 AN007016 Lipid Alterations in ASAH1-Deficient Cells: Insights into Ceramide Accumulation and Lysosomal Dysfunction Cultured cells Human Metabolic disease Harvard Medical School LC-MS
ST004167 AN006918 Targeted Lipidomic Profiling of STBD1 Knockdown in Clear Cell Renal Carcinoma Cells Renal cancer cells Human Cancer The Affiliated Cancer Hospital of Zhengzhou University LC-MS
ST004163 AN006910 Targeted Lipid Profiling of HEK and iPSC derived iMG Cell Models with GBA1 Loss-of-Function Cultured cells Human Metabolic disease Denali Therapeutics LC-MS
ST004163 AN006910 Targeted Lipid Profiling of HEK and iPSC derived iMG Cell Models with GBA1 Loss-of-Function Cultured cells Human Parkinsons disease Denali Therapeutics LC-MS
ST004059 AN006716 Targeted Lipid and Metabolite Profiling in Brains of ATP13A2 Knockout Mice Brain Mouse Neurodegenerative disease Denali Therapeutics LC-MS
ST004059 AN006716 Targeted Lipid and Metabolite Profiling in Brains of ATP13A2 Knockout Mice Brain Mouse Parkinsons disease Denali Therapeutics LC-MS
ST003769 AN006188 Characterization of brain‐derived extracellular vesicle lipids in Alzheimer's disease Brain Human Alzheimers disease University of Melbourne LC-MS
ST002505 AN004127 A Mammalian Conserved Circular RNA CircLARP2 Regulates Hepatocellular Carcinoma Metastasis and Lipid Metabolism (Part 1) Cultured cells Human Cancer University of Science and Technology of China LC-MS
ST000142 AN000225 H1299 13C-labeled Cell Study Lung Human Cancer University of Kentucky LC-MS
  logo